SBIR/STTR Research Award

Fluorescent reporters for real time single cell Pol III transcription measurement

Award identifier 6efcc8534c9612819abd19100bc901025f9ee762fd6a4417192155441f4f5247Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$176,165

Program and phase

SBIR · Phase I

Award year

2017

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
LUCERNA INC
Proposal award date
2017-02-01
Contract end date
2019-01-31
UEI
J3MWGA6WFCG3
Solicitation number
PA15-269
Topic code
400

Research abstract

SUMMARY RNA polymerase III Pol III is increasingly recognized as an important drug target and a rapidly developing area of academic research Pol III is responsible for generating RNAs that are critical for cell growth such as tRNAs certain rRNAs and various noncoding RNAs involved in processes such as mRNA splicing These RNAs are required for cell growth proliferation and differentiation and disrupting the pathways that control Pol III is now thought to be valuable for targeting cancer and obesity Despite the importance of Pol III little is known about the pathways that regulate Pol III transcription This is largely due to the absence of simple and robust reporters for Pol III activity This is in contrast to reporter assays for Pol II promoters for mRNA transcription these reporters comprise Pol II promoters controlling reporter genes such as green fluorescent protein and have been the major driver for drug discovery for mRNA transcription inhibitors However Pol III generates RNAs that cannot be translated As a result nearly all studies of Pol III rely on Northern blotting which is slow and not suited to high throughput screening efforts At Lucerna we have developed a photostable RNA mimic of red fluorescent protein termed Corn and demonstrated that this RNA can serve as a robust fluorescent reporter for Pol III promoters By simply creating a Pol III promoter that controls the synthesis of the Corn RNA fluorescence can be readily detected without the need to synthesize a protein We have demonstrated this concept using the S subtype of a Pol III promoter Interestingly we found marked cell to cell variation in Pol III transcription after cells are exposed to serum and other growth promoting signals Therefore the goal of this Phase I SBIR project is to develop this simple and genetically encodable Corn reporters for live cell imaging and measurement of all three subtypes of Pol III transcription Further we will develop this reporter system so that it can be used in flow cytometry analysis allowing Pol III transcription to be monitored in hundreds of thousands of cells over time For phase II we will adapt our Pol III reporters into marketable toolkits validate the Pol III reporters in disease relevant cell lines and use the Cas CRISPR technology to image endogenous Pol III transcription activity Together the plasmids and kits generated in this project will result in the first Pol III reporters and will therefore constitute an important commercial product that will have wide utility in the academic RNA research community and will enable discovery of small molecule inhibitors of this previously hard to assay class of drug targets PROJECT NARRATIVE RNA polymerase III Pol III is responsible for of total cellular transcription and Pol III activity generates critical RNAs that have been linked to cell homeostasis and disease pathogenesis The lack of real time imaging of Pol III transcription dynamics in cells has limited our ability to understand Pol III activation and the cell to cell variability in Pol III gene expression that occurs in response to stimuli In this project Lucerna will develop a simple genetically encodable fluorescence reporter for monitoring Pol III transcription in real time in live cells which will provide a valuable research tool to study Pol III dynamics and to enable drug discovery targeting Pol III transcription pathways

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

22 SBIR/STTR records share this UEI (2011–2025). Reported award amounts total $10,266,039. Reported amounts are not federal obligations.

Phases: Phase I, Phase II, Phase II – Direct to Phase II

Agencies: Department of Health and Human Services, National Science Foundation

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.